In an AD rat model with Aβ1-40 injection, the hippocampus showed significantly increased mRNA and protein expression of IL-1β 16 days after injection [51] and presented upregulation of other inflammatory mediators after 21 days [52]. This evidence concerns the gene IL1B and Alzheimer disease.